Medtronic (MDT) Superinvestor holders
36 of the superinvestors we track hold Medtronic (MDT) in their latest 13F filings, $6.9B in total.
Summary
The largest holder is Jean-Marie Eveillard (First Eagle Investment Management), with $1.1B, 1.8% of the portfolio.
In their latest quarter: 5 opened a new position, 19 added, 11 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Jean-Marie Eveillard First Eagle Investment Management |
Added | 13,783,983 | $1.1B | 1.8% | Q2 2026 |
| Arrowstreet Capital | Added | 12,892,710 | $1.0B | 0.4% | Q2 2026 |
| WCM Investment Management | Trimmed | 10,826,014 | $876M | 1.6% | Q2 2026 |
| Dodge & Cox | Added | 7,875,898 | $616M | 0.3% | Q2 2026 |
| Howard Gleicher Aristotle Capital Management |
Trimmed | 6,293,698 | $492M | 1.0% | Q2 2026 |
| Hotchkis & Wiley Hotchkis & Wiley Capital Management |
Added | 5,789,077 | $453M | 1.3% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 4,396,781 | $344M | 0.2% | Q2 2026 |
| Mark Donovan Boston Partners |
Added | 3,802,116 | $297M | 0.3% | Q2 2026 |
| Richard Pzena Pzena Investment Management |
Trimmed | 3,078,785 | $266M | 0.8% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Added | 3,299,627 | $258M | 0.1% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 3,240,847 | $254M | 0.2% | Q2 2026 |
| Jim Simons Renaissance Technologies |
New position | 3,167,741 | $248M | 0.3% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Added | 2,511,730 | $196M | 1.9% | Q2 2026 |
| Ric Dillon Diamond Hill Capital Management |
Trimmed | 1,684,110 | $132M | 1.1% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 696,347 | $54M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 573,001 | $45M | 0.1% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 447,301 | $39M | 0.0% | Q3 2026 |
| Ray Dalio Bridgewater Associates |
Added | 482,525 | $38M | 0.2% | Q2 2026 |
| David Katz Matrix Asset Advisors |
Trimmed | 426,624 | $37M | 3.0% | Q3 2026 |
| Man Group Man Group plc |
Added | 416,155 | $33M | 0.1% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Trimmed | 363,349 | $28M | 0.3% | Q2 2026 |
| David Vogel Voloridge Investment Management |
New position | 343,680 | $27M | 0.1% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 182,300 | $14M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 113,168 | $10M | 0.0% | Q3 2026 |
| Tony Yoseloff Davidson Kempner Capital Management |
New position | 114,800 | $9M | 0.2% | Q2 2026 |
| Robert Olstein Olstein Capital Management |
Held | 73,000 | $6M | 1.4% | Q1 2026 |
| Jeremy Grantham GMO |
Added | 71,306 | $6M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 65,665 | $5M | 0.0% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Trimmed | 58,900 | $5M | 0.2% | Q3 2026 |
| First Manhattan First Manhattan Co |
Added | 52,309 | $4M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 40,535 | $3M | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
New position | 31,504 | $2M | 0.0% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 13,397 | $1M | 0.0% | Q2 2026 |
| Mark Boyar Boyar Asset Management |
Trimmed | 7,453 | $643,119 | 0.4% | Q3 2026 |
| Josef Lakonishok LSV Asset Management |
Added | 6,342 | $547,000 | 0.0% | Q3 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 200 | $15,646 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 36 |
| Q1 2026 | 38 |
| Q4 2025 | 37 |
| Q3 2025 | 38 |
| Q2 2025 | 40 |
| Q1 2025 | 40 |
| Q4 2024 | 43 |
| Q3 2024 | 46 |
Questions about Medtronic
Which superinvestors own Medtronic?
36 of the superinvestors we track hold Medtronic (MDT) in their latest 13F filings, $6.9B in total. Jean-Marie Eveillard, Arrowstreet Capital, WCM Investment Management, Dodge & Cox, Howard Gleicher, Hotchkis & Wiley.
Who is the largest superinvestor holder of MDT?
The largest holder is Jean-Marie Eveillard (First Eagle Investment Management), with $1.1B, 1.8% of the portfolio.
From Medtronic's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.